Synthesis, anti-human immunodeficiency virus and anti-hepatitis B virus activities of novel oxaselenolane nucleosides.
Du
J
J
Department of Medicinal Chemistry, College of Pharmacy, University of Georgia, Athens 30602, USA.
Surzhykov
S
S
Lin
J S
JS
Newton
M G
MG
Cheng
Y C
YC
Schinazi
R F
RF
Chu
C K
CK
D019380:Anti-HIV Agents / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D000998:Antiviral Agents / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D003596:Cytosine / Q000031:analogs & derivatives; D005437:Flucytosine / Q000031:analogs & derivatives / Q000494:pharmacology; D006678:HIV / Q000187:drug effects*; D006515:Hepatitis B virus / Q000187:drug effects*; D006801:Humans; D007202:Indicators and Reagents; D008968:Molecular Conformation; D015394:Molecular Structure; D009705:Nucleosides / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D013329:Structure-Activity Relationship
D019380:Anti-HIV Agents; D000998:Antiviral Agents; D007202:Indicators and Reagents; D009705:Nucleosides; D003596:Cytosine; D005437:Flucytosine